{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:41:02Z","timestamp":1792215662672,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Institutes of Health\/ National Cancer Institute Support Grant P30","award":["CA008748."],"award-info":[{"award-number":["CA008748."]}]},{"name":"the National Institutes of Health\/ National Cancer Institute Support Grant P30","award":["CA008748."],"award-info":[{"award-number":["CA008748."]}]},{"name":"the National Institutes of Health\/ National Cancer Institute Support Grant P30","award":["CA008748."],"award-info":[{"award-number":["CA008748."]}]},{"name":"the National Institutes of Health\/ National Cancer Institute Support Grant P30","award":["CA008748."],"award-info":[{"award-number":["CA008748."]}]},{"name":"the National Institutes of Health\/ National Cancer Institute Support Grant P30","award":["CA008748."],"award-info":[{"award-number":["CA008748."]}]},{"name":"the National Institutes of Health\/ National Cancer Institute Support Grant P30","award":["CA008748."],"award-info":[{"award-number":["CA008748."]}]},{"name":"the National Institutes of Health\/ National Cancer Institute Support Grant P30","award":["CA008748."],"award-info":[{"award-number":["CA008748."]}]},{"name":"the National Institutes of Health\/ National Cancer Institute Support Grant P30","award":["CA008748."],"award-info":[{"award-number":["CA008748."]}]},{"name":"the National Institutes of Health\/ National Cancer Institute Support Grant P30","award":["CA008748."],"award-info":[{"award-number":["CA008748."]}]},{"name":"the National Institutes of Health\/ National Cancer Institute Support Grant P30","award":["CA008748."],"award-info":[{"award-number":["CA008748."]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11102-026-01770-x","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:15:10Z","timestamp":1792199710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["68Ga-Pentixafor PET\/MRI for identifying corticotroph adenomas in Cushing disease: a pilot study"],"prefix":"10.1007","volume":"29","author":[{"given":"Rodrigo","family":"Fano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Nosov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcin Agridag","family":"Ucpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Lyashchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Theodorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Tabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Schoder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3722-1889","authenticated-orcid":false,"given":"Eliza B.","family":"Geer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"8","key":"1770_CR1","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BMK, Findling JW et al (2015) Treatment of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 100(8):2807\u20132831. https:\/\/doi.org\/10.1210\/jc.2015-1818","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1770_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1210\/jcem.86.1.7093","volume":"86","author":"J Lindholm","year":"2001","unstructured":"Lindholm J, Juul S, J\u00f8rgensen JOL et al (2001) Incidence and late prognosis of Cushing\u2019s syndrome: a population-based study. J Clin Endocrinol Metab 86(1):117\u2013123. https:\/\/doi.org\/10.1210\/jcem.86.1.7093","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1770_CR3","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/foc.2007.23.3.4","volume":"23","author":"J Jagannathan Jr","year":"2007","unstructured":"Jagannathan J, Sheehan JP, Jane JA Jr (2007) Evaluation and management of Cushing syndrome in cases of negative sellar magnetic resonance imaging. Neurosurg Focus 23(3):E3. https:\/\/doi.org\/10.3171\/foc.2007.23.3.4","journal-title":"Neurosurg Focus"},{"issue":"12","key":"1770_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"1770_CR5","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1210\/jc.2012-3943","volume":"98","author":"JJ Wind","year":"2013","unstructured":"Wind JJ, Lonser RR, Nieman LK, DeVroom HL, Chang R, Oldfield EH (2013) The lateralization accuracy of inferior petrosal sinus sampling in 501 patients with Cushing\u2019s disease. J Clin Endocrinol Metab 98(6):2285\u20132293. https:\/\/doi.org\/10.1210\/jc.2012-3943","journal-title":"J Clin Endocrinol Metab"},{"key":"1770_CR6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgag265","author":"L Bouchard","year":"2026","unstructured":"Bouchard L, Lazard A, Jean C et al (2026) Is the diagnosis of Cushing disease moving beyond bilateral inferior petrosal sinus sampling? J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgag265","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1770_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3803\/EnM.2025.2728","volume":"41","author":"M Reincke","year":"2026","unstructured":"Reincke M, Apaydin T, Kakashvili M, Albert NL, Thorsteinsdottir J, Schweizer JROL et al (2026) New sparks and spots: molecular imaging with positron emission tomography will change management of Cushing\u2019s disease. Endocrinol Metab (Seoul) 41(1):49\u201356. https:\/\/doi.org\/10.3803\/EnM.2025.2728","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1770_CR8","doi-asserted-by":"publisher","first-page":"753524","DOI":"10.1155\/2014\/753524","volume":"2014","author":"F Barbieri","year":"2014","unstructured":"Barbieri F, Thellung S, W\u00fcrth R et al (2014) Emerging targets in pituitary adenomas: role of the CXCL12\/CXCR4-R7 system. Int J Endocrinol 2014:753524. https:\/\/doi.org\/10.1155\/2014\/753524","journal-title":"Int J Endocrinol"},{"key":"1770_CR9","unstructured":"Wu Y, Wu Y, Yao B, et al (2024) Diagnostic accuracy and value of CXCR4-targeted PET\/MRI using 68Ga-pentixafor for tumor localization in Cushing disease. Radiology. [Published online ahead of print]."},{"issue":"8","key":"1770_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/RLU.0000000000004244","volume":"47","author":"J Ding","year":"2022","unstructured":"Ding J, Tong A, Hacker M, Feng M, Huo L, Li X (2022) Usefulness of 68Ga-pentixafor PET\/CT on diagnosis and management of Cushing syndrome. Clin Nucl Med 47(8):669\u2013676. https:\/\/doi.org\/10.1097\/RLU.0000000000004244","journal-title":"Clin Nucl Med"},{"issue":"6","key":"1770_CR11","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1007\/s00259-026-07821-6","volume":"53","author":"B Yao","year":"2026","unstructured":"Yao B, Liu Y, Wu Y, Cui M, Ma Z, Qiao N, Zhang S, Wang Y, Xie F, Guan Y, Yao Z, Zhang Z, Ye H, Wang Y, Zhao Y, Wu Y, Zhang Q (2026) The value of targeting CXCR4 with 68Ga-Pentixafor PET\/MRI for Cushing\u2019s disease: a retrospective cohort study. Eur J Nucl Med Mol Imaging 53(6):4199\u20134210. https:\/\/doi.org\/10.1007\/s00259-026-07821-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1770_CR12","doi-asserted-by":"publisher","first-page":"1797818","DOI":"10.3389\/or.2026.1797818","volume":"20","author":"L Liu","year":"2026","unstructured":"Liu L, Zhang J (2026) Progress in the application of 68Ga-Pentixafor PET\/CT in lung cancer: a review. Oncol Rev 20:1797818. https:\/\/doi.org\/10.3389\/or.2026.1797818","journal-title":"Oncol Rev"},{"issue":"4","key":"1770_CR13","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1097\/AOG.0000000000002355","volume":"130","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Obstetric Practice","year":"2017","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Obstetric Practice (2017) Guidelines for diagnostic imaging during pregnancy and lactation. Comm Opin 723 Obstet Gynecol 130(4):e210\u2013e216. https:\/\/doi.org\/10.1097\/AOG.0000000000002355","journal-title":"Comm Opin 723 Obstet Gynecol"},{"key":"1770_CR14","doi-asserted-by":"publisher","unstructured":"Hesse L, Haberbosch L (2026) Functional pituitary adenoma imaging. Rev Endocr Metab Disord. https:\/\/doi.org\/10.1007\/s11154-026-10063-4","DOI":"10.1007\/s11154-026-10063-4"},{"issue":"4","key":"1770_CR15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3174\/ajnr.A0930","volume":"29","author":"CD Gandhi","year":"2008","unstructured":"Gandhi CD, Meyer SA, Patel AB, Johnson DM, Post KD (2008) Neurologic complications of inferior petrosal sinus sampling. AJNR Am J Neuroradiol 29(4):760\u2013765. https:\/\/doi.org\/10.3174\/ajnr.A0930","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"1770_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/BF03343772","volume":"23","author":"K Obuobie","year":"2000","unstructured":"Obuobie K, Davies JS, Ogunko A, Scanlon MF (2000) Venous thrombo-embolism following inferior petrosal sinus sampling in Cushing\u2019s disease. J Endocrinol Invest 23(8):542\u2013544. https:\/\/doi.org\/10.1007\/BF03343772","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1770_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4261\/1305-3825.DIR.4279-11.0","volume":"18","author":"AR Deipolyi","year":"2012","unstructured":"Deipolyi AR, Karaosmano\u011flu A, Habito CM, Brannan S, Wicky S, Hirsch JA, Oklu R (2012) The role of bilateral inferior petrosal sinus sampling in the diagnostic evaluation of Cushing syndrome. Diagn Interv Radiol 18(1):132\u2013138. https:\/\/doi.org\/10.4261\/1305-3825.DIR.4279-11.0","journal-title":"Diagn Interv Radiol"},{"issue":"1","key":"1770_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13550-023-00993-4","volume":"13","author":"S Martin","year":"2023","unstructured":"Martin S, Viertl D, Janz A et al (2023) Influence of corticosteroid treatment on CXCR4 expression in DLBCL. EJNMMI Res 13(1):42. https:\/\/doi.org\/10.1186\/s13550-023-00993-4","journal-title":"EJNMMI Res"},{"key":"1770_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fmed.2018.00276","volume":"5","author":"E Carolina","year":"2018","unstructured":"Carolina E, Kato T, Khanh VC et al (2018) Glucocorticoid impaired the wound healing ability of endothelial progenitor cells by reducing the expression of CXCR4 in the PGE2 pathway. Front Med (Lausanne) 5:276. https:\/\/doi.org\/10.3389\/fmed.2018.00276","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"1770_CR20","doi-asserted-by":"publisher","first-page":"E1322","DOI":"10.1152\/ajpendo.00678.2013","volume":"306","author":"L Besedovsky","year":"2014","unstructured":"Besedovsky L, Linz B, Dimitrov S, Groch S, Born J, Lange T (2014) Cortisol increases CXCR4 expression but does not affect CD62L and CCR7 levels on specific T cell subsets in humans. Am J Physiol Endocrinol Metab 306(11):E1322\u2013E1329. https:\/\/doi.org\/10.1152\/ajpendo.00678.2013","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01770-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01770-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01770-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:01:47Z","timestamp":1792213307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01770-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1770"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01770-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"13 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was funded by the National Institutes of Health\/ National Cancer Institute Support Grant P30 CA008748. Viviane Tabar, MD is associated with BlueRock Therapeutics (Clinical Trial Investigator, Consultant, Contracted Research) and Robeaute (Consultant). Andrew Lin, MD is associated with Bristol Myers Squibb (Grant Recipient). Eliza Geer, MD is associated with Sparrow and Recordati Rare Diseases (Grant Recipient), Crinetics, Xeris, Camurus, Lundbeck, Recordati, Corcept and AnaCardio (Consultant), and is an Associate Editor for Pituitary although played no role in the Journal\u2019s evaluation of this manuscript.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"170"}}